1. Home
  2. STRRP vs LIMNW Comparison

STRRP vs LIMNW Comparison

Compare STRRP & LIMNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRRP
  • LIMNW
  • Stock Information
  • Founded
  • STRRP N/A
  • LIMNW N/A
  • Country
  • STRRP United States
  • LIMNW United States
  • Employees
  • STRRP 194
  • LIMNW N/A
  • Industry
  • STRRP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LIMNW
  • Sector
  • STRRP Health Care
  • LIMNW
  • Exchange
  • STRRP Nasdaq
  • LIMNW Nasdaq
  • Market Cap
  • STRRP N/A
  • LIMNW N/A
  • IPO Year
  • STRRP N/A
  • LIMNW N/A
  • Fundamental
  • Price
  • STRRP $8.99
  • LIMNW $0.20
  • Analyst Decision
  • STRRP
  • LIMNW
  • Analyst Count
  • STRRP 0
  • LIMNW 0
  • Target Price
  • STRRP N/A
  • LIMNW N/A
  • AVG Volume (30 Days)
  • STRRP N/A
  • LIMNW N/A
  • Earning Date
  • STRRP N/A
  • LIMNW N/A
  • Dividend Yield
  • STRRP N/A
  • LIMNW N/A
  • EPS Growth
  • STRRP N/A
  • LIMNW N/A
  • EPS
  • STRRP N/A
  • LIMNW N/A
  • Revenue
  • STRRP N/A
  • LIMNW N/A
  • Revenue This Year
  • STRRP N/A
  • LIMNW N/A
  • Revenue Next Year
  • STRRP N/A
  • LIMNW N/A
  • P/E Ratio
  • STRRP N/A
  • LIMNW N/A
  • Revenue Growth
  • STRRP N/A
  • LIMNW N/A
  • 52 Week Low
  • STRRP N/A
  • LIMNW N/A
  • 52 Week High
  • STRRP N/A
  • LIMNW N/A
  • Technical
  • Relative Strength Index (RSI)
  • STRRP 40.66
  • LIMNW N/A
  • Support Level
  • STRRP $9.01
  • LIMNW N/A
  • Resistance Level
  • STRRP $9.04
  • LIMNW N/A
  • Average True Range (ATR)
  • STRRP 0.09
  • LIMNW 0.00
  • MACD
  • STRRP -0.03
  • LIMNW 0.00
  • Stochastic Oscillator
  • STRRP 0.00
  • LIMNW 0.00

About STRRP Star Equity Holdings Inc. Series A Cumulative Perpetual Preferred Stock

Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.

About LIMNW Liminatus Pharma Inc. Warrants

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

Share on Social Networks: